Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Postsynaptic congenital myasthenic syndrome
Congenital myasthenic syndrome 2A
A congenital myasthenic syndrome characterized by autosomal dominant inheritance of postsynaptic neuromuscular junction defects, early-onset progressive muscle weakness, and prolonged opening and activity of the acetylcholine receptor channel that has material basis in heterozygous mutation in the CHRNB1 gene on chromosome 17p13.
This condition has no sub-types.